Quantitative microsatellite analysis to delineate the commonly deleted region 1p22.3 in mantle cell lymphomas

Genes Chromosomes and Cancer

Volumn 45, Issue 10, 2006, Pages 883-892

  Balakrishnan, Asha ^a   Von Neuhoff, Nils ^a   Rudolph, Cornelia ^a   Kamphues, Kathrin ^a   Schraders, Margit ^b   Groenen, Patricia ^b   Van Krieken, Johan H J M ^b   Callet Bauchu, Evelyne ^c   Schlegelberger, Brigitte ^a   Steinemann, Doris ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^c CENTRE HOSPITALIER LYON SUD   (France)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN BAX;

ADULT; AGED; APOPTOSIS; ARTICLE; B CELL LYMPHOMA; BCL10 GENE; CHROMOSOME 1P; CHROMOSOME DELETION; CHROMOSOME LOSS; CHROMOSOME TRANSLOCATION; CLCA2 GENE; CONTROLLED STUDY; DNA DETERMINATION; FEMALE; GENE; GENE IDENTIFICATION; GENE LOCATION; GENE LOCUS; GENE MAPPING; HOMOZYGOTE; HUMAN; HUMAN CELL; MALE; MANTLE CELL LYMPHOMA; MICROSATELLITE MARKER; NONHODGKIN LYMPHOMA; PATHOGENESIS; PRIORITY JOURNAL; PROGNOSIS; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SH3GLB1 GENE; TUMOR SUPPRESSOR GENE;

ADULT; AGED; AGED, 80 AND OVER; CHROMOSOME DELETION; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 1; DNA, NEOPLASM; FEMALE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; LYMPHOMA, MANTLE-CELL; MALE; MICROSATELLITE REPEATS; MIDDLE AGED; POLYMERASE CHAIN REACTION;

EID: 33748515459     PISSN: 10452257     EISSN: 10982264     Source Type: Journal    
DOI: 10.1002/gcc.20352     Document Type: Article

References (38)

1. Bea S, Ribas M, Hernandez JM, Bosch F, Pinyol M, Hernández L, García JL, Flores T, González M, López-Guillermo A, Piris MA, Cardesa A, Montserrat E, Miró R, Campo E. 1999. Increased number of chromosomal imbalances and high-level DNA amplifications in mantle cell lymphoma are associated with blastoid variants. Blood 93:4365-4374.
2. Bernard M, Gressin R, Lefre're F, Drenou B, Branger B, Caulet-Maugendre S, Tass P, Brousse N, Valensi F, Milpied N, Voilat L, Sadoun A, Ghandour C, Hunault M, Leloup R, Mannone L, Hermine O, Lamy T. 2001. Blastic variant of MCL: A rare but highly aggressive subtype. Leukemia 15:1785-1791.
3. Bertoni F, Zucca E, Cotter FE. 2004. Molecular basis of mantle cell lymphoma. Br J Haematol 124:130-140.
4. Bullinger L, Leupolt E, Schaffner C, Mertens D, Bentz M, Lichter P, Dohner H, Stilgenbauer S. 2000. BCL10 is not the gene inactivated by mutation in the 1p22 deletion region in mantle cell lymphoma. Leukemia 14:1490-1492.
5. +-activated chloride channel genes CLCA1 and CLCA2 is downregulated in human colorectal cancer. DNA Cell Biol 20:331-338.
6. Campo E, Raffeld M, Jaffe ES. 1999. Mantle-cell lymphoma. Semin Hematol 36:115-127.
7. Cuddeback SM, Yamaguchi H, Komatsu K, Miyashita T, Yamada M, Wu C, Singh S, Wang HG. 2001. Molecular cloning and characterization of Bif-1. A novel Src homology 3 domain-containing protein that associates with Bax. J Biol Chem 276:20559-20565.
8. de Leeuw RJ, Davies JJ, Rosenwald A, Bebb G, Gascoyne RD, Dyer MJ, Staudt LM, Martinez-Climent JA, Lam WL. 2004. Comprehensive whole genome array CGH profiling of mantle cell lymphoma model genomes. Hum Mol Genet 13:1827-1837.
9. Elble RC, Pauli BU. 2001. Tumor suppression by a proapoptotic calcium-activated chloride channel in mammary epithelium. J Biol Chem 276:40510-40517.
10. Erikson J, Finan J, Tsujimoto Y, Nowell PC, Croce CM. 1984. The chromosome 14 breakpoint in neoplastic B cells with the t(11;14) translocation involves the immunoglobulin heavy chain locus. Proc Natl Acad Sci USA 81:4144-4148.
11. Ginzinger DG, Godfrey TE, Nigro J, Moore DH, II, Suzuki S, Pallavicini MG, Gray JW, Jensen RH. 2000. Measurement of DNA copy number at microsatellite loci using quantitative PCR analysis. Cancer Res 60:5405-5409.
12. Gruber AD, Pauli BU. 1999a. Clustering of the human CLCA gene family on the short arm of chromosome 1 (1p22-31). Genome 42:1030-1032.
13. +-activated chloride channel CLCA2. Cancer Res 59:5488-5491.
14. Hinds PW, Dowdy SF, Eaton EN, Arnold A, Weinberg RA. 1994. Function of a human cyclin gene as an oncogene. Proc Natl Acad Sci USA 91:709-713.
15. Huang X, Gollin SM, Raja S, Godfrey TE. 2002. High-resolution mapping of the 11q13 amplicon and identification of a gene, TAOS1, that is amplified and overexpressed in oral cancer cells. Proc Natl Acad Sci USA 99:11369-11374.
16. Kohlhammer H, Schwaenen C, Wessendorf S, Holzmann K, Kestler HA, Kienle D, Barth T, Moller P, Ott G, Kalla J, Radlwimmer B, Pscherer A, Stilgenbauer S, Dohner H, Lichter P, Bentz M. 2004. Genomic DNA-chip hybridization in t(11;14)-positive mantle cell lymphomas shows a high frequency of aberrations and allows a refined characterization of consensus regions. Blood 104:795-801.
17. Leroux D, Le Marc'Hadour F, Gressin R, Jacob MC, Keddari E, Monteil M, Caillot P, Jalbert P, Sotto JJ. 1991. Non-Hodgkin's lymphomas with t(11;14)(q13;q32): A subset of mantle zone/intermediate lymphocytic lymphoma? Br J Haematol 77:346-353.
18. Leupolt E, Bullinger L, Bentz M, Ott G, Müller-Hermelink HK, Barth TFE, Möller P, Lichter P, Döhner H, Stilgenbauer S. 1999. Comprehensive molecular cytogenetic analysis of mantle cell lymphoma. Blood 94 (Suppl 1):517a.
19. Li X, Cowell JK, Sossey-Alaoui K. 2004. CLCA2 tumour suppressor gene in 1p31 is epigenetically regulated in breast cancer. Oncogene 23:1474-1480.
20. Lovec H, Grzeschiczek A, Kowalski MB, Moray T. 1994. Cyclin D1/bcl-1 cooperates with myc genes in the generation of B-cell lymphoma in transgenic mice. EMBO J 13:3487-3495.
21. Nigro JM, Takahashi MA, Ginzinger DG, Law M, Passe S, Jenkins RB, Aldape K. 2001. Detection of 1p and 19q loss in oligodendroglioma by quantitative microsatellite analysis, a real-time quantitative polymerase chain reaction assay. Am J Pathol 158:1253-1262.
22. Pierrat B, Simonen M, Cueto M, Mestan J, Ferrigno P, Heim J. 2001. SH3GLB, a new endophilin-related protein family featuring an SH3 domain. Genomics 71:222-234.
23. Raffeld M, Jaffe ES. 1991. Bcl-1, t(11;14), and mantle cell-derived lymphomas. Blood 78:259-263.
24. Rosenberg CL, Wong E, Petty EM, Bale AE, Tsujimoto Y, Harris NL, Arnold A. 1991. PRAD1, a candidate BCL1 oncogene: Mapping and expression in centrocytic lymphoma. Proc Natl Acad Sci USA 88:9638-9642.
25. Rubio-Moscardo F, Climent J, Siebert R, Piris MA, Martin-Subero JI, Nielander I, Garcia-Conde J, Dyer MJ, Terol MJ, Pinkel D, Martinez-Climent JA. 2005. Mantle cell lymphoma genotypes identified with CGH to BAC microarrays define a leukemic subgroup of disease and predict patient outcome. Blood 105:4445-4454.
26. Rudolph C, Liehr T, Steinemann D, Emura M, Daibata M, Matsuo Y, Emi N, Abe M, Lai R, Mrasek K, Claussen U, Schlegelberger B. 2006. Different breakage-prone regions on chromosome 1 detected in t(11;14)-positive mantle cell lymphoma cell lines and multiple myeloma cell lines are associated with different tumor progression-related mechanisms. Cytogenet Genome Res 112:213-221.
27. Rudolph C, Steinemann D, von Neuhoff N, Gadzicki D, Ripperger T, Drexler HG, Mrasek K, Liehr T, Claussen U, Emura M, Schrock E, Schlegelberger B. 2004. Molecular cytogenetic characterization of the mantle cell lymphoma (MCL) cell line GRANTA-519. Cancer Genet Cytogenet 153:144-150.
28. Schlegelberger B, Metzke S, Harder S, Zühlke-Jenisch R, Zhang Y, Siebert R. 1999. Classical and molecular cytogenetics of tumor cells. In: Wegener R, editor. Cytogenetics. New York: Springer-Verlag, p. 151.
29. Schraders M, Pfundt R, Straatman HM, Janssen IM, Geurts van Kessel A, Schoenmakers EF, van Krieken JH, Groenen PJ. 2005. Novel chromosomal imbalances in mantle cell lymphoma detected by genome-wide array-based comparative genomic hybridization. Blood 105:1686-1693.
30. Schwaenen C, Nessling M, Wessendorf S, Salvi T, Wrobel G, Radlwimmer B, Kestler HA, Haslinger C, Stilgenbauer S, Dohner H, Bentz M, Lichter P. 2004. Automated array-based genomic profiling in chronic lymphocytic leukemia: Development of a clinical tool and discovery of recurrent genomic alterations. Proc Natl Acad Sci USA 101:1039-1044.
31. Steinemann D, Siebert R, Harder S, Martin-Subero I, Kettwig G, Hinzmann B, Gesk S, Tiemann M, Merz H, Rosenthal A, Grote W, Morris SW, Schlegelberger B. 2000. Frequent allelic loss of the BCL10 gene in lymphomas with the t(11;14)(q13;q32). Leukemia 15:474-475.
32. Swerdlow SH, Williams ME. 2002. From centrocytic to mantle cell lymphoma: A clinicopathologic and molecular review of 3 decades. Hum Pathol 33:7-20.
33. Tagawa H, Karnan S, Suzuki R, Matsuo K, Zhang X, Ota A, Morishima Y, Nakamura S, Seto M. 2005. Genome-wide array-based CGH for mantle cell lymphoma: Identification of homozygous deletions of the proapoptotic gene BIM. Oncogene 24:1348-1358.
34. Tsujimoto Y, Yunis J, Onorato-Showe L, Erikson J, Nowell PC, Croce CM. 1984. Molecular cloning of the chromosomal breakpoint of B-cell lymphomas and leukemias with the t(11;14) chromosome translocation. Science 224:1403-1406.
35. Weisenburger DD, Armitage JO. 1996. Mantle cell lymphoma-An entity comes of age. Blood 87:4483-4494.
36. Willis TG, Jadayel DM, Du MQ, Peng H, Perry AR, Abdul-Rauf M, Price H, Karran L, Majekodunmi O, Wlodarska I, Pan L, Crook T, Hamoudi R, Isaacson PG, Dyer MJ. 1999. Bcl10 is involved in t(1;14)(p22;q32) of MALT B cell lymphoma and mutated in multiple tumor types. Cell 96:35-45.
37. Wlodarska I, Pittaluga S, Hagemeijer A, De Wolf-Peeters C, Van Den Berghe H. 1999. Secondary chromosome changes in mantle cell lymphoma. Haematologica 84:594-599.
38. Zhang Q, Siebert R, Yan M, Hinzmann B, Cui X, Xue L, Rakestraw KM, Naeve CW, Beckmann G, Weisenburger DD, Sanger WG, Nowotny H, Vesely M, Callet-Bauchu E, Salles G, Dixit VM, Rosenthal A, Schlegelberger B, Morris SW. 1999. Inactivating mutations and overexpression of BCL10, a caspase recruitment domain-containing gene, in MALT lymphoma with t(1;14)(p22;q32). Nat Genet 22:63-68.